Professionals can also directly access courses from AAMDSIF at the Online Academy.
MDS Rounds: An AAMDSIF Visiting Faculty Program
The CME/CE-accredited MDS Rounds Program provides a forum for health care professionals who care for patients with bone marrow failure disorders to address issues related to the diagnosis and treatment of patients with myelodysplastic syndromes (MDS). Participants will learn the latest information on new therapies and advances in the management of MDS through lecture and case studies developed and presented by an expert in hematology/oncology.
Designed for a standard one-hour program format, this program has been developed by the Aplastic Anemia and MDS International Foundation (AAMDSIF) and accredited by USF Health. It is available at no charge for medical centers to provide for their professional staff.
Children and Adults with Severe Aplastic Anemia: Treatment Options, Care and Support
Sponsored jointly by the National Marrow Donor Program®/Be The Match® and the Aplastic Anemia and MDS International Foundation.
• Wednesday, March 29, 2017
• Time: 11:00 a.m. - 12:15 p.m. Central Daylight Time
In this free continuing education webinar a physician and social worker will present current research and case examples to illustrate treatment options and common experiences for patients with aplastic anemia and their families. The goal of this activity is to ensure that members of a multidisciplinary team have the knowledge and skills necessary to apply the standards of care to their practice and healthcare setting for patients with severe aplastic anemia. Attendees are encouraged to submit questions for a Q&A discussion.
Hematology, oncology and BMT nurses; hematology, oncology and BMT social workers at intermediate to advanced levels of practice, experience and licensure; transplant center coordinators; payer case managers and other allied health professionals.
David A Margolis, MD: Program Director, Bone Marrow Transplant, Children's Hospital of Wisconsin and Professor, The Medical College of Wisconsin
Sheila Dodds, MSW: Pediatric Social Worker, Bone Marrow Transplant Program, Children’s Hospital of Wisconsin
This program is accredited for nurses, social workers and medical technologists.
Advances in Treating MDS and Related Bone Marrow Failure Diseases: The Role of Nurses in Managing Therapy and Personalizing Care
Breakfast Symposium at ONS Annual Congress in Denver, CO
Thursday, May 4, 2017
6:00 – 7:30 am, Hyatt Regency Denver, Centennial F-G
This CE-certified program will provide participants with the latest information on the pathophysiology and differential diagnosis of MDS and related bone marrow failure diseases; risk and prognostic scoring systems; treatment options for low-risk and high-risk MDS, AML, and MDS/MPN overlap; disease management; and ways to address psychosocial and quality-of-life issues to improve the care of this patient population.
Regional Bone Marrow Failure Disease Symposia
Clinicians caring for both children and adults are frequently faced with patients with low blood counts and the challenge of initial management and work-up. This symposium will provide participants with the most up-to-date review of scientific and clinical research related to the biology and management of pediatric and adult bone marrow failure diseases, including anemia, myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), and paroxysmal nocturnal hemoglobinuria (PNH). The presenters will focus on the latest advances in the diagnosis, genetic characteristics, pathology and treatment options for these diseases, including the importance of recognizing adult presentations of inherited marrow failure syndromes and recent discoveries in inherited bone marrow failure defects.
Omaha, Nebraska - May 9, 2017
Cosponsored with University of Nebraska Medical Center
Milwaukee, Wisconsin - November 4, 2016
Cosponsored with Medical College of Wisconsin
Portland, Oregon - September 14, 2016
Cosponsored with Oregon Health and Science University
Recorded Education Programs
Clinical Management of MDS/MPN: A Mountain of Evidence for Treatment Selection in MDS/MPN
CME-certified Satellite Lunch Symposium, preceding the 58th ASH Annual Meeting
Plan to attend the symposium that will provide an in-depth and up-to-date review of research related to the biology, prognosis, natural history, and therapeutic management of patients with MDS, MPN and MDS/MPN overlap.
Register Today! ccfcme.org/MDS16
Treatment Decision-Making Through the Spectrum of MDS
Explaining MDS to patients can be challenging for healthcare professionals. The disease process is complex, the prognosis variable, and treatment options must be tailored for each patient. This series of three continuing education programs - one each for low risk MDS, high risk MDS, and stem cell transplantation - focuses on effective communication to ensure optimal outcomes when managing patients with MDS.
The target audience for these programs is oncologists, hematologists, oncology nurses, and other healthcare providers who diagnose and manage MDS patients.
Each program provides 0.5 CE credit.
Assessing Anemia in Older Patients and When to Suspect MDS
AA&MDSIF is committed to providing quality and timely educational activities for community hematologists/oncologists, gerontologists, and primary care physicians. This webcast is a studio-based discussion between an academic-based hematologist/oncologist specializing in MDS and a community-based oncologist. These two professionals discuss cases to review the evaluation and work-up of anemia and cytopenias seen in general practice and to review symptoms, clinical presentations, treatment options and post-diagnosis issues common within MDS.
B. Douglas Smith, MD, Professor of Oncology and Eric J. Seifter, MD, Associate Professor of Medicine and Oncology, Johns Hopkins University School of Medicine
Upon completion of this program, viewers will be able to
- Identify the symptoms that in conjunction with anemia, should lead to suspected MDS
- Discuss diagnostic techniques, including bone marrow biopsy
- Review treatment options for patients with MDS, including supportive care, and assistant in the development of appropriate treatment goals for MDS patients
- Understand how immunomodulatory drugs work against MDS
- Be familiar with benefits, safety margins, and adverse effects of medications used to treat MDS
Part 1: Diagnosing MDS
Part 2: MDS Diagnostic Workup, Staging and Supportive Therapy
Part 3: Beyond Supportive Therapies
International Scientific Symposium 2016
Global experts in bone marrow failure disease come to our signature event, the two-day International Scientific Symposium, to present and compare data in high-level sessions that help improve treatments, advance new research theories and foster collaboration. These events typically consist of 40+ presentations by the world's top researchers and medical experts. The Foundation then produces summaries of the scientific presentations in layman's language for distribution to our patients and families so that they also benefit from the exchange of information among leaders in the field of bone marrow failure. All AAMDSIF symposia earn exceptionally high marks from the health professionals who attend.
- The Genetics of Bone Marrow Failure
- Transplant Treatments for Bone Marrow Failure
- The Immunology of Bone Marrow Failure Disease
- Pathophysiology and New Molevular Targets of Bone Marrow Failure
- Non-Transplant Options for Aplastic Anemia and PNH
- Non-Transplant Treatment Options for MDS
- Transplant and Treatment for Older Patients with Aplastic Anemia
- Diagnosis of Bone Marrow Failure in the Genomics Era
- Cutting Edge Approaches to Treating Aplastic Anemia
ONS Congress Satellite Symposium
Latest Developments in Treating MDS – An Update on Molecular Testing, Low-Risk and High-Risk MDS Therapies, and Disease Management
This breakfast symposium at the 2016 ONS Annual Congress focused on the role of the oncology nurse in shared decision-making with myelodysplastic syndromes (MDS) patients. Topics include treatment options for low-risk and high-risk MDS, the impact of comorbidities and psychosocial factors in therapy choices, and communication techniques for nurses to use for patient education and treatment management. Case studies were be used to illustrate the challenges of monitoring MDS and adapting therapy to improve outcome and quality of life for patients.